Compound information
- Natural Products
- ZC1045081
- Molecular Formula
- C26H40N6O6
- Molecular Weight
- 532.300933 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[[1-[(2R)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]piperidine-4-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C26H40N6O6/c1-17(2)15-21(31-26(37)38-16-18-7-4-3-5-8-18)23(34)32-13-10-19(11-14-32)22(33)30-20(24(35)36)9-6-12-29-25(27)28/h3-5,7-8,17,19-21H,6,9-16H2,1-2H3,(H,30,33)(H,31,37)(H,35,36)(H4,27,28,29)/t20-,21-/m1/s1
- InChI Key
- KFDGYYKEYONTAZ-NHCUHLMSSA-N
- SMILES
- CC(C)C[C@@H](NC(=O)OCc1ccccc1)C(=O)N1CCC(C(=O)N[C@H](CCCNC(=N)N)C(=O)O)CC1
- Source
- ZINC000012296223
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 38 | Ring Count | 2 |
Heteroatom Count | 12 | Rotatable Bond Count | 13 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 186.94 Å2 | LogP | 0.554 |
LogS | -2.498 | LogD | 1.041 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.004 | Pgp substrate | 0.998 |
HIA | 0.001 | F20 % | 0.965 |
F30 % | 0.001 | Caco-2 | -6.77 |
MDCK | -5.975 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.123 | PPB | 51.492 |
VD | 0.273 | Fu | 0.567 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.366 |
CYP2A6 substrate | 0.151 | CYP2B6 substrate | 0.351 |
CYP2C19 inhibitor | 0.024 | CYP2C19 substrate | 0.265 |
CYP2C8 substrate | 0.424 | CYP2C9 inhibitor | 0.171 |
CYP2C9 substrate | 0.287 | CYP2D6 inhibitor | 0.02 |
CYP2D6 substrate | 0.222 | CYP2E1 substrate | 0.299 |
CYP3A4 inhibitor | 0.039 | CYP3A4 substrate | 0.833 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.736 | CL | 3.321 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.1 | Hepatotoxicity | 0.088 |
Mutagenicity | 0.099 | Rat Oral Acute Toxicity | 0.039 |
FDAMDD | 0.234 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.108 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.931 | IGC50 | 1.906 |
LC50FM | -0.485 | LC50DM | -0.786 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.479 | NR-AR-LBD | 0.407 |
NR-AhR | 0.003 | NR-Aromatase | 0.017 |
NR-ER | 0.409 | NR-ER-LBD | 0.35 |
NR-PPAR-gamma | 0.425 | SR-ARE | 0.163 |
SR-ATAD5 | 0.295 | SR-HSE | 0.092 |
SR-MMP | 0.009 | SR-p53 | 0.08 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.